Drug Overview: ReNu with MoistureLoc Side Effects and Claims
Bausch & Lomb voluntarily withdrew its soft contact lens solution, ReNu with MoistureLoc, from the market on April 13, 2006. ReNu with MoistureLoc was a solution used for storing, cleaning, and moisturizing soft contact lenses. ReNu was approved by the FDA (Food and Drug Administration) in 2004 and reportedly brought Bausch & Lomb $45 million in revenue in 2005. The ReNu claim was that it cleaned and disinfected contact lenses without the need to rub them. This cleaning method may have contributed to the increase in fungal infections that is now identified as a ReNu with MoistureLoc side effect.
Suffered harm from ReNu with MoistureLoc? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights.
Bausch & Lomb took action after the CDC (Centers for Disease Control) reported an alarming number of cases of a usually rare fungal infection of the eye called Fusarium keratitis, which can cause serious eye damage and blindness. The FDA began an investigation to see if Fusarium keratitis is a ReNu with MoistureLoc side effect. See Drug Warnings: ReNu with MoistureLoc Side Effects and Risks for information on FDA action.
Check out the following articles for more information about ReNu with MoistureLoc, filing an ReNu with MoistureLoc lawsuit and finding an ReNu with MoistureLoc attorney.
Suffered harm from ReNu with MoistureLoc? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights. | 
State Law Center
|
Legal Resource Directory
|
Legal Articles
|
Insurance Advice and Quotes
|
FreeAdvice Answers
|
Community Forums
